(Q41629817)

5 October 2017

1 reference

title

Behavioral effects of clozapine and dopamine receptor subtypes (English)

1 reference

5 October 2017

1

Josselyn SA

1 reference

5 October 2017

Miller R

2

1 reference

5 October 2017

Beninger RJ

series ordinal

3

1 reference

5 October 2017

publication date

1 September 1997

1 reference

Neuroscience & Biobehavioral Reviews

5 October 2017

published in

1 reference

5 October 2017

volume

21

1 reference

5 October 2017

issue

5

1 reference

5 October 2017

page(s)

531-558

1 reference

Clozapine's anti-acetylcholine property modulates its antistereotypic action in the mesolimbic sytem

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Evidence for dopamine receptor stimulation by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The "neuroleptic" antipsychotic drugs. 1. Mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D1 receptor antagonists in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of chlorpromazine and three metabolites on behavioral responses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dissociating the effects of altered dopaminergic function on performance and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Receptor subtype-specific dopaminergic agents and conditioned behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Regional selectivity of neuroleptic drugs: An argument for site specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Asymmetric rotational (circling) behavior, a dopamine-related asymmetry: preliminary findings in unmedicated and never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Correlation of severity of psychiatric patients' delusions with right hemispatial inattention (left-turning behavior).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Sensorimotor gating and schizophrenia. Human and animal model studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: comparison with typical and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Inhibition and potentiation of apomorphine-induced hypermotility in rats by neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

A comparison of clozapine, chlorpromazine, and thioridazine upon DRL performance in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of clozapine, chlorpromazine and diazepam upon adjunctive and schedule controlled behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

A study of the sites of interaction between dopamine and 5-hydroxytryptamine for the production of fluphenazine-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

SCH 39166, a potential antipsychotic drug, does not evoke movement disorders in cebus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Theoretical and methodological considerations on drug discrimination learning

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Discriminative stimulus properties of cocaine and d-amphetamine, and antagonism by haloperidol: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Behavioral effects of some psychopharmacological agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cocaine self-administration is increased by both D1 and D2 dopamine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Biochemical and behavioural properties of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Persistent Dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Influence of SCH 23390, a DA1-receptor antagonist, on the behavioural responsiveness to small and large doses of apomorphine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Clozapine-induced agranulocytosis. A genetic and epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Parameters of self-administration of cocaine in rats under a progressive-ratio schedule.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Monkey models of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Parametric analysis of brain stimulation reward in the rat: III. Effect of performance variables on the reward summation function.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Behavioural effects of serotonin agonists and antagonists in the rat and marmoset.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Haloperidol-induced tolerance to morphine catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Time course of chronic haloperidol and clozapine upon operant rate and duration.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

An examination of methodological refinements, clozapine and fluphenazine in the anhedonia paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Evidence for heterogeneous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Self-stimulation response decrement patterns differentiate clonidine, baclofen and dopamine antagonists from drugs causing performance deficit.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Drugs and Reinforcement Mechanisms: A Critical Review of the Catecholamine Theory

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Catecholamines and self-stimulation: reward and performances effects dissociated

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pimozide and amphetamine have opposing effects on the reward summation function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pimozide attenuates lever pressing for water reinforcement in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

1 reference

7 January 2021

Effect of selective D1 and D2 dopamine receptor antagonists and agonists in Cebus monkeys: implications for acute and tardive dyskinesias. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Behavioral correlations of dopamine receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Lack of acute antipsychotic effect of Sch 23390, a selective dopamine D1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Multiple neurochemical action of clozapine: A quantitative autoradiographic study of DA 2, opiate and benzodiazepine receptors in the rat brain after long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Discriminative stimulus properties of clozapine and chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pharmacological evidence for the subclassification of central dopamine receptors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Stimulation of postsynaptic DA2 receptors produces jerks in reserpine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Presidential Address, 1974. The more or less startling effects of weak prestimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

CLOZAPINE AND AGRANULOCYTOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Common profile of D1 receptor antagonists and atypical antipsychotic drugs revealed by analysis of dopamine turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The involvemet of serotonergic neurons in the central nervous system as the possible mechanism for slow head-shaking behavior induced by methamphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Haloperidol blocks the response-reinstating effects of food reward: a methodology for separating neuroleptic effects on reinforcement and motor processes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Failure of SCH 23390 to function as a discriminative stimulus in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Clozapine attenuates cocaine conditioned place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The role of dopamine in the maintenance and breakdown of D1/D2 synergism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Discriminating between reward and performance: A critical review of intracranial self-stimulation methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of various catecholamine receptor antagonists, muscle relaxation and physical hindrance on shuttlebox self-stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Blockade by neuroleptics of water intake and operant responding for water in the rat: anhedonia, motor deficit, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Scopolamine reverses haloperidol-attenuated lever-pressing for water but not haloperidol-attenuated water intake in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of the dopamine D-1 antagonist SCH 23390 on water intake, water-rewarded operant responding and apomorphine-induced decrease of water intake in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential attenuation of water intake and water-rewarded operant responding by repeated administration of haloperidol and SCH 23390 in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Apomorphine-induced locomotion and gnawing: Evidence that the experimental design greatly influences gnawing while locomotion remains unchanged

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Schizophrenia and the D1 receptor: focus on negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Pimozide-induced suppression of responding: evidence against a block of food reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Disorders of attention and perception in early schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

In vivo binding to dopamine receptors: a correlate of potential antipsychotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

In vivo occupancy of dopamine receptors by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Major psychosis and dopamine: controversial features and some suggestions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Catalepsy induced by SCH 23390 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopaminergic substrates of cocaine-induced place conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antagonism by CGS 8216 and Ro 15-1788, benzodiazepines antagonists, of the action of chlordiazepoxide on a timing behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Reserpinization severs the cooperative but not the oppositional interaction between D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cholinergic mediation of the discriminative stimulus properties of clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: Comparisons with the D-2 enantioselectivity of Ro 22-1319

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: Association with increased non-specific binding of the D-1 ligand [3H]piflutixol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Prolonged psychotic relapse after abrupt clozapine withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Self-administration of d-amphetamine by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Neuroleptic-induced acute dyskinesias in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Atypical neuroleptics increase self-administration of cocaine: An evaluation of a behavioural screen for antipsychotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

GBR 12909 reverses the SCH 23390 inhibition of rewarding effects of brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of clozapine on shuttle-box avoidance responding in rats: comparisons with haloperidol and chlordiazepoxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Response decrement patterns after neuroleptic and non-neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The actions of SCH 23390, a D1 receptor antagonist, on operant and avoidance behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The effects of tranquillizing drugs on timing behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential effects of chlordiazepoxide and d-amphetamine on responding maintained by a DRL schedule of reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Acute effects of neuroleptics on brain self-stimulation thresholds in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effect of neuroleptics and tricyclic antidepressants upon D-amphetamine discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of haloperidol and SCH 23390 on acoustic startle and prepulse inhibition under basal and stimulated conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Neuroleptics have identical potencies in human brain limbic and putamen regions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The major dopamine D2 receptor: molecular analysis of the human D2A subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Molecular neurobiology of dopaminergic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

The third dopamine receptor (D3) as a novel target for antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of some dibenzo-azepines on suppressed and nonsuppressed behavior of squirrel monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Dopaminergic substrates of amphetamine-induced place preference conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Detection of dopamine receptors in the area postrema

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Brain stimulation reward "thresholds" self-determined in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of peripheral and central dopamine blockade on lateral hypothalamic self-stimulation: evidence for both reward and motor deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ-aminobutyric acid, glutamate or serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cloning of ligand-specific cell lines via gene transfer: identification of a D2 dopamine receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

PROBLEMS OF MEASUREMENT AND INTERPRETATION WITH REINFORCING BRAIN STIMULATION.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Stimulus effects of d-amphetamine 1: DA mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Increased grooming behaviour is induced by apomorphine in mice treated with discriminant benzamide derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Neuroleptics and Brain Self-Stimulation Behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Intracranial self-stimulation in rats as a function of various stimulus parameters. II. Influence of haloperidol, pimozide and pipamperone on medial forebrain bundle stimulation with monopolar electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of clozapine, chlorpromazine and haloperidol on schedule-controlled behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Performance on a lever-release, conditioned avoidance response task involves both dopamine D1 and D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of four antipsychotics on punished responding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Differential effects of haloperidol and clozapine on the reinforcing efficacy of food reward in an alleyway reacquisition paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Neuroleptic-Induced "Anhedonia" in Rats: Pimozide Blocks Reward Quality of Food

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Blockade of intracranial self-stimulation by antipsychotic drugs: Failure to correlate with central alpha-noradrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900051-6

7 January 2021

10.1016/S0149-7634(96)00051-6

Identifiers

DOI

1 reference

5 October 2017

1 reference